Kevin H. Chen

发表

Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies

Yupo Ma, M. Golightly, A. Jares, 2016, Oncotarget.

Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia

Yupo Ma, Lai-han Leung, J. C. Petrov, 2018, Leukemia.

Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells

Yupo Ma, W. Tse, E. Leung, 2017, Oncotarget.

Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies

Yupo Ma, Hongyu Zhang, Wenli Zhang, 2020, Stem Cell Reviews and Reports.

Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell Therapy

Yupo Ma, W. Tse, Hongyu Zhang, 2020, Stem Cell Reviews and Reports.

First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial

Yupo Ma, Yi Su, Guang-cui He, 2018, Blood.

Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies

Yupo Ma, Hongyu Zhang, Wenli Zhang, 2020, Stem Cell Reviews and Reports.

A compound chimeric antigen receptor strategy for targeting multiple myeloma

J. C. Petrov, X. Shuai, K. H. Chen, 2017, Leukemia.

Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor

M. Golightly, X. Shuai, A. Jares, 2017, Leukemia.

Possible association of keratoconus progression with gender-affirming hormone therapy: A case report

Kevin H. Chen, Ian C. Uber, Carli M. Deitel, 2023, American journal of ophthalmology case reports.